Evolent Health (EVH) Non Operating Interest Expenses (2016 - 2026)

Evolent Health has reported Non Operating Interest Expenses for 11 years, with the latest figure at $16.9 million in Q2 2026.

• On a quarterly basis, Non Operating Interest Expenses rose 45.32% year-over-year to $16.9 million in Q2 2026; TTM through Jun 2026 was $69.2 million, a 99.37% increase from a year earlier, with the FY2025 full-year figure at $57.5 million, up 132.47% from the prior year.
• Non Operating Interest Expenses was $16.9 million for Q2 2026 at Evolent Health, roughly flat from $16.9 million in the prior quarter.
• The five-year high for Non Operating Interest Expenses was $19.0 million in Q4 2025, with the low at $2.1 million in Q2 2022.
• Average Non Operating Interest Expenses over 5 years is $10.3 million, with a median of $11.0 million recorded in 2025.
• The sharpest annual moves came in 2022 and 2023: Non Operating Interest Expenses slumped 65.76% in 2022, then jumped 573.09% in 2023.
• Over 5 years, Non Operating Interest Expenses stood at $6.4 million in 2022, then jumped by 90.36% to $12.2 million in 2023, then tumbled by 45.09% to $6.7 million in 2024, then jumped by 182.89% to $19.0 million in 2025, then dropped by 11.32% to $16.9 million in 2026.
• The last three Non Operating Interest Expenses figures came in at $16.9 million (Q2 2026), $16.9 million (Q1 2026), and $19.0 million (Q4 2025), per Business Quant data.